Aroa Biosurgery Ltd (AU:ARX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Aroa Biosurgery Ltd has disclosed a change in the indirect interest of Director Brian Ward, with an acquisition of 961,255 Performance Rights, as per a shareholder-approved issuance at the company’s Annual General Meeting on 23 July 2024. The update, which has been reported to the ASX under listing rule 3.19A.2, shows no disposal of securities and maintains Mr. Ward’s substantial holding in the company, including over 33 million fully paid ordinary shares and various tranches of options.
For further insights into AU:ARX stock, check out TipRanks’ Stock Analysis page.